Grosvenorine
CAS No. 156980-60-8
Grosvenorine ( Grosvenorin )
Catalog No. M23682 CAS No. 156980-60-8
Grosvenorine exhibits good antibacterial and antioxidant activities, with its metabolites possessing more potent activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 231 | In Stock |
|
10MG | 342 | In Stock |
|
25MG | 574 | In Stock |
|
50MG | 801 | In Stock |
|
100MG | 1107 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGrosvenorine
-
NoteResearch use only, not for human use.
-
Brief DescriptionGrosvenorine exhibits good antibacterial and antioxidant activities, with its metabolites possessing more potent activities.
-
DescriptionGrosvenorine exhibits good antibacterial and antioxidant activities, with its metabolites possessing more potent activities, intestinal bacteria play an important role in the gastrointestinal metabolism of grosvenorine and significantly affect its pharmacological activities.
-
SynonymsGrosvenorin
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorBacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number156980-60-8
-
Formula Weight740.7
-
Molecular FormulaC33H40O19
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C(O[C@H]2[C@@H]([C@@H]([C@@H](O)[C@H](C)O2)O)O)=C(C3=CC=C(O)C=C3)OC4=CC(O[C@H]5[C@@H]([C@@H]([C@@H](O)[C@H](C)O5)O)O[C@]6([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]6O)CO)=CC(O)=C41
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.The Gastrointestinal Tract Metabolism and Pharmacological Activities of Grosvenorine, a Major and Characteristic Flavonoid in the Fruits of Siraitia grosvenorii.Chem Biodivers. 2015 Nov;12(11):1652-64.
molnova catalog
related products
-
Methyl α-D-mannopyra...
Methyl α-D-mannopyranoside can be used as an intermediate for chemical sythesis and can ?target macrophages in anti-tuberculosis inhalation therapy.
-
Linaroside
Linaroside exhibited 30% inhibition for antimycobacterial activity against Mycobacterium tuberculosis, strain H(37)Rv at 6.25 microg mL(-1) concentration.
-
Anisomycin
An antibiotic that inhibits eukaryotic protein synthesis by inhibiting peptidyl transferase or the 80S ribosome system.